| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |